Janssen-Cilag Ltd, Velcade (bortezomib) 3.5mg powder for solution for injection EU/1/04/274/001
Pierre Fabre Medicament, Busilvex (busulfan) 6mg/ml concentrate for solution for infusion EU/1/03/254/002
Recalls due to concerns that acceptable levels of sterility assurance during manufacture cannot be guaranteed.
Full details are included in the attached PDF files